Galena Settles Investors' Revived Opioid Row For $1.6M
A group of investors has urged a New Jersey federal judge to grant preliminary approval to a $1.6 million settlement with Galena Biopharma Inc. to resolve allegations the company caused a...To view the full article, register now.
Already a subscriber? Click here to view full article